| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 671533 | 72540 | CLORURO DE POTASIO SERRACLINICS 2 MEQ/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | CLORURO DE POTASIO SERRACLINICS 2 MEQ/ML CONCENTRADO PARA SOLUCION PARA PERFUSION , 20 x 20 ml | 2 mEq/ml inyectable 20 ml | 1 | 20 | 1 | 20 x 20 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72540/72540_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72540/72540_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 2616 | LABORATORIOS SERRA PAMIES S.A. | 2016-02-23 | 1 | 1 | 1 | 2016-02-23 | 2016-02-25 | 0 | 2017-12-18 | View Edit Delete | ||||||||||||
| 671623 | 72541 | CLORURO DE SODIO SERRACLINICS 9 mg/ml (0,9%) SOLUCION INYECTABLE | CLORURO DE SODIO SERRACLINICS 9 mg/ml (0,9%) SOLUCION INYECTABLE 50 ampollas de 10 ml | 0,9 % inyectable 10 ml | 1 | 50 | 1 | 50 ampollas de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72541/72541_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72541/72541_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2616 | LABORATORIOS SERRA PAMIES S.A. | 2010-07-16 | 1 | 1 | 1 | 2016-07-15 | 2016-07-15 | 0 | 2017-09-28 | View Edit Delete | ||||||||||||
| 670273 | 61596 | ILOMEDIN 50 MICROGRAMOS/0,5 ML, CONCENTRADO PARA SOLUCION PARA PERFUSION | ILOMEDIN 50 MICROGRAMOS/0,5 ML, CONCENTRADO PARA SOLUCION PARA PERFUSION , 1 ampolla de 0,5 ml | 100 microgramos/ml inyectable 0,5 ml | 1 | 1 | 1 | 1 ampolla de 0,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61596/61596_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61596/61596_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11424 | BAYER HISPANIA S.L. | 1998-01-01 | 1 | 1 | 1 | 1998-01-01 | 1998-01-01 | 1 | 2011-10-11 | View Edit Delete | ||||||||||||
| 665446 | 72359 | GLYPRESSIN 1 mg SOLUCION INYECTABLE | GLYPRESSIN 1 mg SOLUCION INYECTABLE, 5 ampollas de 8,5 ml | 1 mg | 1 | 5 | 1 | 5 ampollas de 8,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72359/72359_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72359/72359_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31840 | FERRING S.A.U. | 2010-06-07 | 1 | 1 | 1 | 2010-06-07 | 2010-06-07 | 1 | 2011-06-28 | View Edit Delete | ||||||||||||
| 665948 | 09528002 | PEYONA 20 mg/ml SOLUCION PARA PERFUSION Y SOLUCION ORAL | PEYONA 20 mg/ml SOLUCION PARA PERFUSION Y SOLUCION ORAL, 10 ampollas de 1 ml | 20 mg/ml ampolla 1 ml | 1 | 10 | 1 | 10 ampollas de 1 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09528002/09528002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09528002/09528002_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 19683 | CHIESI ESPAÑA S.A.U. | 2011-03-01 | 1 | 1 | 1 | 2011-03-01 | 2011-03-01 | 1 | 2011-10-10 | View Edit Delete | ||||||||||||
| 674657 | 70932 | TAKIPRIL HIPERBARICA 20 MG/ML SOLUCION INYECTABLE | TAKIPRIL HIPERBARICA 20 MG/ML SOLUCION INYECTABLE 10 ampollas de 5 ml | 20 mg/ml inyectable 5 ml | 1 | 10 | 1 | 10 ampollas de 5 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70932/70932_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70932/70932_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 306 | B BRAUN MEDICAL S.A. | 2012-10-18 | 1 | 1 | 1 | 2012-10-18 | 2012-10-18 | 1 | 2013-09-19 | View Edit Delete | ||||||||||||
| 672066 | 67455 | DEXAMETASONA KERN PHARMA 4 mg/ml SOLUCION INYECTABLE EFG | DEXAMETASONA KERN PHARMA 4 mg/ml SOLUCION INYECTABLE EFG , 3 ampollas de 1 ml | 4 mg | 1 | 3 | 1 | 3 ampollas de 1 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67455/67455_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67455/67455_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2006-01-13 | 1 | 1 | 1 | 2006-01-13 | 2011-02-17 | 1 | 2012-10-10 | 653560 | View Edit Delete | |||||||||||
| 673665 | 61413 | MINURIN 4 MICROGRAMOS/ML SOLUCIÓN INYECTABLE | MINURIN 4 MICROGRAMOS/ML SOLUCIÓN INYECTABLE , 10 ampollas de 1 ml | 4 microgramos | 1 | 10 | 1 | 10 ampollas de 1 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61413/61413_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61413/61413_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 31840 | FERRING S.A.U. | 1997-09-01 | 1 | 1 | 1 | 1997-09-01 | 1997-09-01 | 1 | 2011-06-28 | View Edit Delete | ||||||||||||
| 676509 | 73054 | ROPIVACAINA KABI 2MG/ML SOLUCION INYECTABLE EFG | ROPIVACAINA KABI 2MG/ML SOLUCION INYECTABLE EFG , 5 ampollas de 10 ml | 2 mg/ml inyectable 10 ml | 1 | 5 | 1 | 5 ampollas de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73054/73054_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73054/73054_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2014-11-11 | 1 | 1 | 1 | 2014-11-11 | 2014-11-13 | 1 | 2015-05-26 | View Edit Delete | ||||||||||||
| 676514 | 73056 | ROPIVACAINA KABI 7,5 MG/ML SOLUCION INYECTABLE EFG | ROPIVACAINA KABI 7,5 MG/ML SOLUCION INYECTABLE EFG , 5 ampollas de 10 ml | 7,5 mg/ml inyectable de 10 ml | 1 | 5 | 1 | 5 ampollas de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73056/73056_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73056/73056_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2014-11-11 | 1 | 1 | 1 | 2014-11-11 | 2014-11-13 | 1 | 2015-05-26 | View Edit Delete | ||||||||||||
| 676516 | 73057 | ROPIVACAINA KABI 10 MG/ML SOLUCION INYECTABLE EFG | ROPIVACAINA KABI 10 MG/ML SOLUCION INYECTABLE EFG , 5 ampollas de 10 ml | 10 mg/ml inyectable 10 ml | 1 | 5 | 1 | 5 ampollas de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73057/73057_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73057/73057_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2014-11-11 | 1 | 1 | 1 | 2014-11-11 | 2014-11-13 | 1 | 2015-05-26 | View Edit Delete | ||||||||||||
| 677339 | 73280 | HIDROCLORURO DE EFEDRINA KABI 30 mg/ml SOLUCION INYECTABLE | HIDROCLORURO DE EFEDRINA KABI 30 mg/ml SOLUCION INYECTABLE, 10 ampollas de 1 ml | 30 mg/ml inyectable 1 ml | 1 | 10 | 1 | 10 ampollas de 1 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73280/73280_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73280/73280_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2011-01-13 | 1 | 1 | 1 | 2011-01-13 | 2011-01-13 | 0 | 2020-04-02 | View Edit Delete | ||||||||||||
| 680397 | 61021 | VITALIPID INFANTIL | VITALIPID INFANTIL, 10 ampollas de 10 ml | 135,3 microgramos/ml + 1 microgramos/ml + 20 microgramos/ml + 640 microgramos/ml inyectable 10 ml | 1 | 10 | 1 | 10 ampollas de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61021/61021_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61021/61021_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 1997-07-01 | 1 | 1 | 1 | 1997-07-01 | 1997-07-01 | 1 | 2011-02-09 | View Edit Delete | ||||||||||||
| 680405 | 61020 | VITALIPID ADULTOS | VITALIPID ADULTOS, 10 ampollas de 10 ml | 194,1 microgramos/ml + 0,5 microgramos/ml + 15 microgramos/ml + 910 microgramos/ml inyectable 10 ml | 1 | 10 | 1 | 10 ampollas de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61020/61020_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61020/61020_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 1997-07-01 | 1 | 1 | 1 | 1997-07-01 | 1997-07-01 | 1 | 2011-02-09 | View Edit Delete | ||||||||||||
| 680371 | 61023 | ETALPHA 2 microgramos SOLUCION INYECTABLE | ETALPHA 2 microgramos SOLUCION INYECTABLE , 10 ampollas de 1 ml | 2 microgramos | 1 | 10 | 1 | 10 ampollas de 1 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61023/61023_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61023/61023_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 25535 | LABORATORIOS RUBIO S.A. | 1996-05-01 | 1 | 1 | 1 | 1996-05-01 | 1996-05-01 | 1 | 2011-09-08 | View Edit Delete | ||||||||||||
| 680389 | 61022 | ETALPHA 1 microgramo SOLUCION INYECTABLE | ETALPHA 1 microgramo SOLUCION INYECTABLE , 10 ampollas de 0,5 ml | 1 microgramo | 1 | 10 | 1 | 10 ampollas de 0,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61022/61022_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61022/61022_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 25535 | LABORATORIOS RUBIO S.A. | 1996-05-01 | 1 | 1 | 1 | 1996-05-01 | 1996-05-01 | 1 | 2011-09-08 | View Edit Delete | ||||||||||||
| 680678 | 61004 | PROGRAF 5 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION | PROGRAF 5 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION , 10 ampollas de 1 ml | 5 mg/ml inyectable 1 ml | 1 | 10 | 1 | 10 ampollas de 1 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61004/61004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61004/61004_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 40569 | ASTELLAS PHARMA S.A. | 1996-07-01 | 1 | 1 | 1 | 1996-07-01 | 1996-07-01 | 1 | 2011-10-26 | View Edit Delete | ||||||||||||
| 677362 | 73563 | SALBUAIR 2.5 mg SOLUCION PARA INHALACION POR NEBULIZADOR | SALBUAIR 2.5 mg SOLUCION PARA INHALACION POR NEBULIZADOR , 60 ampollas de 2,5 ml | 2,5 mg | 1 | 60 | 40 | 60 ampollas de 2,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73563/73563_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73563/73563_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 16620 | LABORATORIO ALDO UNION S.L. | 2011-02-22 | 1 | 1 | 1 | 2011-02-22 | 2011-02-22 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 677363 | 73562 | SALBUAIR 5 mg SOLUCION PARA INHALACION POR NEBULIZADOR | SALBUAIR 5 mg SOLUCION PARA INHALACION POR NEBULIZADOR, 60 ampollas de 2,5 ml | 5 mg | 1 | 60 | 40 | 60 ampollas de 2,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73562/73562_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73562/73562_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 16620 | LABORATORIO ALDO UNION S.L. | 2011-02-22 | 1 | 1 | 1 | 2011-02-22 | 2011-02-22 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 677602 | 73561 | COMBIPRASAL 0.5 mg/2.5 mg SOLUCION PARA INHALACION POR NEBULIZADOR | COMBIPRASAL 0.5 mg/2.5 mg SOLUCION PARA INHALACION POR NEBULIZADOR, 20 ampollas de 2,5 ml | 2,5 mg/0,5 mg | 1 | 20 | 40 | 20 ampollas de 2,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73561/73561_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73561/73561_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 16620 | LABORATORIO ALDO UNION S.L. | 2011-02-22 | 1 | 1 | 1 | 2011-02-22 | 2011-02-22 | 1 | 2011-10-24 | View Edit Delete |
Page 11 of 1035, showing 20 records out of 20697 total, starting on record 201, ending on 220